Professor Ray Chan

@Flinders Deputy Vice-Chancellor (Research) // Professor of Cancer Care Systems and Policy // @NHMRC Investigator // Christ Believer

[Professor Ray Chan @rayychan]

So, do we really know:
What is a comprehensive #cancer centre?
What should we expect them to be, to do, & to do for & with others?

Check out Part II of our work:
https://t.co/435Xoih15i

@theNCI @uicc @COSAoncology @EuropeanCancer @myESMO @ASCO @CancerCareMASCC @CancerAustralia

[The Advertiser @theTiser]

Flinders University researchers have developed a breakthrough drug treatment for sleep apnoea that could gain US approval next year, offering hope to more than one million Australians 😴

📌 READ MORE: https://t.co/P3GgYeLTWR

[Cristiane D Bergerot, PhD, FASCO @crisbergerot]

Powerful talk by @DrN_CancerPCP on patients living with advanced/metastatic cancer
➡️ 1 in 2 face financial toxicity
➡️ 1 in 3 psychological distress
➡️ 1 in 4 physical/daily living challenges
Yet many feel “invisible” in survivorship care.
Time to rethink the model

[Cristiane D Bergerot, PhD, FASCO @crisbergerot]

@DrN_CancerPCP highlighted @CancerCareMASCC @ASCO guideline on survivorship care for people w advanced/metastatic cancer:
🔹 Routine, longitudinal needs assessment
🔹 Multidisciplinary, coordinated care
🔹 Inclusion of caregivers
🔹 Focus on quality of life across the trajectory

[Darcy Burbage, DNP, RN, AOCN @DarcyBurbage]

Early bird pricing ends for #ONSCongress on 3/26! Register now to keep up to date w/ @oncologynursing education, networking & the energy that sets the tone for the year ahead 💙🧡!!
https://t.co/ullptxSK9j

[Australian College of Nursing (ACN) @acn_nursing]

Nurse practitioners can now issue cause-of-death certificates and witness non-written health directions in the ACT. ACN calls on other jurisdictions to follow suit, and remove all unnecessary barriers preventing NPs from delivering holistic care #NursesAreTheSolution

[MASCC @CancerCareMASCC]

A new research article from Shirley SW Tse, Henry CY Wong and colleagues looks at the cost-effectiveness of Mepitel Film for prevention of acute radiation dermatitis (ARD) in breast cancer, from a Canadian healthcare payer’s perspective.

Read more here: https://t.co/lPn25ct2BU

[COSA @COSAoncology]

For World Cancer Day, COSA and CNSA have released a joint position statement on the contribution of nurses to cancer survivorship care in Australia, with recommendations for strengthening survivorship care nationally. Read more https://t.co/7DFy8sAR3c https://t.co/5WsZxeVD7U

[Nicolas Hart @DrNicolasHart]

On #WorldCancerDay we launch our joint @COSAoncology and @CNSA_ORG position statement on the vital contribution of nurses to cancer survivorship care: https://t.co/E5dlL4fCCK

This statement recognises nurses as central to coordinated, equitable, accessible + person-centred care.

[Caring Futures Cancer Survivorship Program @survonc]

🌟 We care about equity in survivorship care for all. 🌟 We work together so people can live well with & beyond cancer. This #WorldCancerDay, we stand #UnitedByUnique — placing people at the heart of care. #CancerSurvivorship #ResearchThatMatters #FlindersCancerSurvivorship

[NeuRA (Neuroscience Research Australia) @neuraustralia]

Researchers have found that repurposing a safe and affordable blood pressure medication may help prevent cancer-related cognitive impairment.

NeuRA (Neuroscience Research Australia) PhD candidate, Delyse McCaffrey, led the study, ​‘Candesartan, an angiotensin receptor blocker, prevents cognitive impairment in female mice with mammary cancer’, which was published in @BrainBehavImm .

“Up to 75% of cancer patients report cognitive symptoms, with around 30% experiencing persistent deficits that interfere with daily functioning and quality of life,” Ms McCaffrey said.

“This can impact a person’s ability to think, learn, remember, or make decisions. Despite the profound economic and psychosocial burden, there are limited therapeutic options.

"Cancer-related cognitive impairment is associated with a combination of factors, including neuroinflammation, oxidative stress, and blood-brain barrier dysfunction, with evidence suggesting dysregulation of the renin-angiotensin system (RAS), which modulates these processes.

“A key advantage of candesartan is its ability to cross the blood – brain barrier and modulate neurobiological processes linked to cognitive decline in cancer, making it an attractive candidate for repurposing to prevent cancer-related cognitive impairment,” Dr Walker said. She worked alongside her supervisors Dr Adam K. Walker and Professor Cynthia Shannon Weickert, and in collaboration with Professor @rayychan at @Flinders University and Professor Janette Vardy @VardyJanette at the @Sydney_Uni.

You can read the full article here - https://t.co/TcpzXkZ9cJ

You can read the study here - https://t.co/UFZLrWoQvU

[Nicolas Hart @DrNicolasHart]

Our first article for 2026 - planning for ‘when’ and not ‘if’ we get cancer - through building accessible and high-quality survivorship care systems. Our analysis and call to action: https://t.co/r1sY9T2Aq4

[MASCC @CancerCareMASCC]

A new Clinical Practice Statement is now available from our Oncodermatology Study Group on the prevention and management of acute radiation dermatitis with Mepitel Film and Hydrofilm:

https://t.co/MsEfOEziZG

#SuppOnc

[MASCC @CancerCareMASCC]

In this MASCC Short Talk, @rayychan shares some key highlights of the work presented at #MASCC25 around patient navigation. Watch now: https://t.co/6PIO0QuDnl

#SuppOnc

[MASCC @CancerCareMASCC]

Don’t forget to submit your abstracts for #MASCC26!

Visit our website to learn more, and be sure to get your abstract in by January 16 (or December 17 if you plan to apply for a Conference Scholarship).

https://t.co/nVIynYDFFK

#SuppOnc #SurvOnc #GlobOnc #PallOnc #Oncology

[Professor Ray Chan @rayychan]

@GPONursing Congratulations Annie

[Ash Paul @pash22]

Geriatric assessment in older adults with cancer: A global scoping review of barriers and strategies to implementation
https://t.co/CD0BXd9BzW via @chitchadkitchen et al @lucypgeridoc @drol007

[Journal of Geriatric Oncology @JGeriOnc]

Geriatric assessment in older adults with cancer: A global scoping review of barriers and strategies to implementation https://t.co/XDlKf7b51s @chitchadkitchen @rayychan @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier

[Chad Han, AdvAPD, PhD @chitchadkitchen]

🚨 New #OpenAccess article!
We mapped the global maze of #GeriatricAssessment in #CancerCare 🧓👵
🔍 27 barriers & 17 strategies to GA implementation
✅ Telehealth, nurse-led models, policy advocacy & more
🛠️ Tool template + upcoming #DelphiStudy

Read here 👉 https://t.co/K89re6akEa
#GeriatricOncology #ImplementationScience #JGO #ResearchImpact
🙏 With @WilliamDale_MD, @rayychan, Seyi Agbejule, @LKasherman, Catherine Paterson, @AnnaMislang, @martine_puts, @kristenhaase, Jolyn Johal @survonc

[Professor Ray Chan @rayychan]

@74chos @CancerCareMASCC @fumikochino Awwwww

[Professor Ray Chan @rayychan]

I was rejected by the Hong Kong educational system when I was 16. My score didn’t make the cut off to proceed to A-level (UK system). I then pursued education in Australia which changed my life

#TweetYourRejection #medTwitter @CancerCareMASCC @fumikochino

[Fumiko Ladd Chino, MD, FASCO @fumikochino]

#medTwitter #medstudentTwitter reminder: Failure is part success.

Today I was organizing some papers and found these 3 #rejection letters from medical school (from Stanford, Yale, and UCSF).

Normalizing rejection is just as important as sharing your wins. #tweetyourRejection

[Professor Ray Chan @rayychan]

@fumikochino @CancerCareMASCC So gracious! Same to you!